+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiation Oncology Market - Global Forecast 2026-2032- Product Image
Radiation Oncology Market - Global Forecast 2026-2032- Product Image
Sale

Radiation Oncology Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968884
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radiation Oncology Market is projected to reach USD 16.39 Billion in 2026. It is expected to continue growing at a CAGR of 9.04%, reaching USD 28.13 Billion by 2032.

Radiation oncology is a core pillar of multidisciplinary cancer care, with radiotherapy used for curative, adjuvant, neoadjuvant, and palliative treatment across common solid tumors. The International Agency for Research on Cancer reported about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022 and projects more than 35 million new cases by 2050, reinforcing sustained demand for radiation therapy capacity.

Growth in radiation oncology is being shaped by adoption of IMRT, IGRT, SBRT, brachytherapy, proton therapy, adaptive radiotherapy, and AI-enabled treatment planning. For providers, the strategic priority is no longer equipment acquisition alone; it is building high-throughput, quality-assured radiation oncology programs that improve access, precision, patient experience, and clinical outcomes.

Transformative Shifts in the Radiation Oncology Landscape

The radiation oncology landscape is shifting from hardware-centered modernization to digitally coordinated cancer care. Linear accelerator replacement cycles increasingly emphasize image guidance, motion management, stereotactic capability, and interoperability with oncology information systems, treatment planning systems, imaging archives, and electronic health records.

Clinical practice is also moving toward hypofractionation, precision dose delivery, and multidisciplinary pathways. Shorter treatment courses can improve patient convenience and department capacity, while advanced techniques such as SBRT and adaptive radiotherapy require stronger physics support, quality assurance, staff training, and evidence-based patient selection.

Cumulative Impact of Artificial Intelligence in Radiation Oncology

Artificial intelligence is increasingly relevant across radiation oncology workflows, including image segmentation, organ-at-risk contouring, treatment plan optimization, quality checks, adaptive replanning, scheduling, and outcomes analytics. Its cumulative value lies in reducing repetitive workload, improving consistency, and enabling clinicians to focus on complex decision-making.

AI must be deployed with governance, validation, cybersecurity controls, and human oversight. Because radiotherapy errors can have serious consequences, leaders should align AI adoption with AAPM, ASTRO, ESTRO, and local regulatory expectations, using prospective monitoring, bias assessment, and performance audits before scaling AI-driven clinical workflows.

Key Regional Insights Across Global Radiation Oncology

North America remains a leading radiation oncology market due to high cancer screening uptake, mature reimbursement, advanced clinical trial networks, and broad availability of IMRT, IGRT, SBRT, proton therapy, and brachytherapy across the United States and Canada. Europe benefits from established cancer plans, cross-border research collaboration, guideline-driven care, and strong public health systems, although radiotherapy capacity, modernization pace, and waiting times vary by country.

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia invest in oncology infrastructure, digital treatment planning, image-guided radiotherapy, and advanced radiotherapy techniques to address a large and aging cancer population. Latin America shows rising demand for radiation therapy, with Brazil and Mexico acting as major service hubs, but access remains uneven between large urban centers and underserved rural areas. The Middle East, especially Gulf markets, is building specialized cancer centers and adopting advanced oncology technologies, while Africa faces the largest access gaps, making workforce development, equipment financing, maintenance models, and service sustainability critical to improving radiotherapy availability.

Key Group Insights for Radiation Oncology Market Strategy

The G7 leads in installed radiotherapy capacity, clinical evidence generation, reimbursement sophistication, and adoption of advanced modalities such as SBRT, adaptive radiotherapy, proton therapy, and AI-assisted planning. The European Union supports harmonized cancer policy, research funding, radiotherapy quality frameworks, and cross-border clinical collaboration, while NATO countries often overlap with high-income markets where resilience, cybersecurity, medical supply continuity, and protection of digital oncology infrastructure are increasing strategic priorities.

BRICS markets account for a large share of future cancer burden and represent major opportunities for linear accelerators, treatment planning software, oncology information systems, and training partnerships. ASEAN countries are improving cancer infrastructure at different speeds, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing varied capacity needs linked to population distribution, reimbursement models, and specialist availability. GCC countries are investing in premium cancer centers, proton therapy evaluation, digital oncology systems, and international clinical partnerships aligned with national health transformation agendas.

Key Country Insights in Radiation Oncology

The United States is a benchmark market for advanced radiotherapy, value-based care experimentation, clinical trials, and technology adoption, while Canada emphasizes publicly funded access, provincial capacity planning, and evidence-based implementation. Mexico and Brazil face growing cancer demand and opportunities for public-private investment in radiotherapy infrastructure, whereas the United Kingdom, Germany, France, Italy, and Spain remain major European radiotherapy markets with strong guideline-driven care, national cancer strategies, and ongoing modernization programs. Russia maintains significant oncology infrastructure needs across a large geography, requiring continued attention to equipment availability, workforce distribution, and regional access.

China and India are central to future radiation oncology expansion because of population scale, rising cancer incidence, and ongoing hospital investment in linear accelerators, imaging systems, and cancer center capacity. Japan and South Korea are leaders in precision radiotherapy, imaging integration, quality assurance, and technology adoption, supported by advanced hospital networks and aging populations with high cancer care needs. Australia combines strong clinical governance with advanced treatment availability across major metropolitan centers, while also addressing geographic access challenges through networked oncology services and referral pathways.

Actionable Recommendations for Radiation Oncology Leaders

Industry leaders should prioritize capacity models that match cancer incidence, referral patterns, staffing, machine utilization, treatment complexity, and expected maintenance requirements. Investment decisions should evaluate total cost of ownership, uptime, service support, cybersecurity, interoperability, clinical workflow impact, and reimbursement alignment rather than headline equipment specifications alone.

Providers should standardize contouring, treatment planning, peer review, image guidance protocols, incident learning, and quality assurance to support safe scaling of advanced techniques. Partnerships with academic centers, technology suppliers, professional societies, and public health agencies can accelerate workforce training, AI validation, remote planning support, maintenance resilience, and equitable access to modern radiation oncology services.

Research Methodology for Radiation Oncology Analysis

This executive summary is based on secondary research from recognized public and professional sources, including IARC and WHO cancer statistics, national cancer plans, peer-reviewed oncology literature, clinical society guidance, regulatory information, and publicly available health infrastructure data. Insights are synthesized to reflect validated trends in radiotherapy demand, technology adoption, access gaps, clinical workflow modernization, and regional radiation oncology development.

The methodology emphasizes triangulation across epidemiology, installed-capacity indicators, reimbursement context, clinical practice patterns, regulatory direction, workforce requirements, and technology roadmaps. Qualitative interpretation is used only where supported by consistent evidence from credible sources, ensuring the analysis remains data-backed, transparent, and relevant for executive decision-making.

Conclusion: The Future of Radiation Oncology

Radiation oncology is entering a period of accelerated modernization driven by rising global cancer incidence, demand for precision treatment, hypofractionated care pathways, and the integration of AI-enabled clinical workflows. The strongest organizations will be those that combine advanced technology with disciplined quality assurance, workforce development, cybersecurity readiness, and patient-centered access strategies.

As cancer burden rises toward 2050, radiotherapy capacity will remain essential to sustainable oncology care. Leaders that invest in scalable infrastructure, interoperable software, validated AI, robust clinical governance, and equitable service models will be best positioned to improve outcomes and capture long-term market opportunity without compromising safety or quality.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Radiation Oncology Market, by Technology
7.1. Introduction
7.2. Brachytherapy
7.2.1. High Dose Rate
7.2.2. Low Dose Rate
7.3. Intensity Modulated Radiation Therapy
7.3.1. Step And Shoot Imrt
7.3.2. Volumetric Modulated Arc Therapy
7.4. Proton Therapy
7.4.1. Passive Scattering
7.4.2. Pencil Beam Scanning
7.5. Stereotactic Body Radiotherapy
7.5.1. Cyberknife
7.5.2. Linac Based
7.6. Three Dimensional Conformal Radiation Therapy
8. Radiation Oncology Market, by Component
8.1. Introduction
8.2. Hardware
8.3. Services
8.4. Software
9. Radiation Oncology Market, by Delivery Mode
9.1. Introduction
9.2. External Beam
9.2.1. Rotational Beam
9.2.2. Stationary Beam
9.3. Intraoperative
9.3.1. Minimally Invasive
9.3.2. Open Surgery
10. Radiation Oncology Market, by Application
10.1. Introduction
10.2. Breast Cancer
10.3. Head And Neck Cancer
10.4. Lung Cancer
10.5. Prostate Cancer
11. Radiation Oncology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Freestanding
11.2.2. Hospital Affiliated
11.3. Cancer Treatment Centers
11.3.1. Multispecialty
11.3.2. Standalone
11.4. Hospitals
11.4.1. Private
11.4.2. Public
12. Radiation Oncology Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Radiation Oncology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Radiation Oncology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Accuray Incorporated
16.2. Becton, Dickinson and Company
16.3. Bionix LLC
16.4. BrainLab AG
16.5. Canon Inc.
16.6. Carl Zeiss AG
16.7. Eckert and Ziegler AG
16.8. Elekta AB
16.9. GE HealthCare Technologies Inc.
16.10. Hitachi, Ltd.
16.11. Hologic, Inc.
16.12. IntraOp Medical, Inc.
16.13. Ion Beam Applications S.A.
16.14. Isoray Inc.
16.15. Koninklijke Philips N.V.
16.16. Nordion Inc.
16.17. Optivus Proton Therapy, Inc.
16.18. P-Cure LTD.
16.19. Panacea Medical Technologies Pvt. LTD.
16.20. Provision Healthcare, LLC
16.21. Siemens Healthineers AG
16.22. Stryker Corporation
16.23. Sumitomo Heavy Industries, LTD
16.24. Theragenics Corporation
16.25. ViewRay, Inc.
List of Figures
FIGURE 1. GLOBAL RADIATION ONCOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RADIATION ONCOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL RADIATION ONCOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL RADIATION ONCOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL RADIATION ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL RADIATION ONCOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL RADIATION ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL HIGH DOSE RATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL HIGH DOSE RATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL HIGH DOSE RATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LOW DOSE RATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LOW DOSE RATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LOW DOSE RATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INTENSITY MODULATED RADIATION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INTENSITY MODULATED RADIATION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INTENSITY MODULATED RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL STEP AND SHOOT IMRT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL STEP AND SHOOT IMRT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL STEP AND SHOOT IMRT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL VOLUMETRIC MODULATED ARC THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL VOLUMETRIC MODULATED ARC THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL VOLUMETRIC MODULATED ARC THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PROTON THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PROTON THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PASSIVE SCATTERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PASSIVE SCATTERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PASSIVE SCATTERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PENCIL BEAM SCANNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PENCIL BEAM SCANNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PENCIL BEAM SCANNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STEREOTACTIC BODY RADIOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STEREOTACTIC BODY RADIOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL STEREOTACTIC BODY RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CYBERKNIFE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CYBERKNIFE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CYBERKNIFE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LINAC BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LINAC BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LINAC BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL THREE DIMENSIONAL CONFORMAL RADIATION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL THREE DIMENSIONAL CONFORMAL RADIATION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL THREE DIMENSIONAL CONFORMAL RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL EXTERNAL BEAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL EXTERNAL BEAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL EXTERNAL BEAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ROTATIONAL BEAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ROTATIONAL BEAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ROTATIONAL BEAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL STATIONARY BEAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL STATIONARY BEAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL STATIONARY BEAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL INTRAOPERATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL INTRAOPERATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL INTRAOPERATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HEAD AND NECK CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HEAD AND NECK CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HEAD AND NECK CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PROSTATE CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PROSTATE CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PROSTATE CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL FREESTANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL FREESTANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL FREESTANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL MULTISPECIALTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL MULTISPECIALTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL MULTISPECIALTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL STANDALONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL STANDALONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL STANDALONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 159. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 162. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 163. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 164. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 165. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 166. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 167. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 168. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 169. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 172. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 173. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 189. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 192. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 193. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 194. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 195. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 196. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 197. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 198. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 203. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 208. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 209. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 210. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 211. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 212. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 213. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 214. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 215. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 218. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 219. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 220. GCC RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. GCC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. GCC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 223. GCC RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 224. GCC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 225. GCC RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 226. GCC RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 227. GCC RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 228. GCC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 229. GCC RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 230. GCC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. GCC RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. GCC RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 233. GCC RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 234. GCC RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 250. BRICS RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. BRICS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. BRICS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 253. BRICS RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 254. BRICS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 255. BRICS RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 256. BRICS RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 257. BRICS RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 258. BRICS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 259. BRICS RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 260. BRICS RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. BRICS RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. BRICS RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 263. BRICS RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 264. BRICS RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 265. G7 RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 266. G7 RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. G7 RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 268. G7 RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 269. G7 RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 270. G7 RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 271. G7 RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 272. G7 RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 273. G7 RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 274. G7 RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 275. G7 RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. G7 RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. G7 RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 278. G7 RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 279. G7 RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 280. NATO RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 281. NATO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 282. NATO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 283. NATO RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 284. NATO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 285. NATO RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 286. NATO RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 287. NATO RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 288. NATO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 289. NATO RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 290. NATO RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 291. NATO RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. NATO RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 293. NATO RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 294. NATO RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 295. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 311. CANADA RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. CANADA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 313. CANADA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 314. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 315. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 316. CANADA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 317. CANADA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 318. CANADA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 319. CANADA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 320. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 321. CANADA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. CANADA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. CANADA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 324. CANADA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 325. CANADA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 326. MEXICO RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 328. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 329. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 330. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 331. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 332. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 333. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 334. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 335. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 336. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 337. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 339. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 340. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 341. BRAZIL RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2017-2032 (USD MILLION)
TABLE 345. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 348. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 349. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2017-2032 (USD MILLION)
TABLE 350. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2017-2032 (USD MILLION)
TABLE 351. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 353. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2017-2032 (USD MILLION)
TABLE 354. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2017-2032 (USD MILLION)
TABLE 355. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 356. UNITED KINGDOM RADIATION ONCOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 357. UNITED KINGDOM RADIATION ON

Companies Mentioned

  • Accuray Incorporated
  • Becton, Dickinson and Company
  • Bionix LLC
  • BrainLab AG
  • Canon Inc.
  • Carl Zeiss AG
  • Eckert and Ziegler AG
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • IntraOp Medical, Inc.
  • Ion Beam Applications S.A.
  • Isoray Inc.
  • Koninklijke Philips N.V.
  • Nordion Inc.
  • Optivus Proton Therapy, Inc.
  • P-Cure LTD.
  • Panacea Medical Technologies Pvt. LTD.
  • Provision Healthcare, LLC
  • Siemens Healthineers AG
  • Stryker Corporation
  • Sumitomo Heavy Industries, LTD
  • Theragenics Corporation
  • ViewRay, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.39 Billion
Forecasted Market Value ( USD ) by 2032 $ 28.13 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2026-2034 - Product Image

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Radiation Oncology Market Size, Share & Trends Analysis Report by Treatment, Technology, Application, Target Customer, Region, and Growth Forecasts, 2026-2033 - Product Image

Radiation Oncology Market Size, Share & Trends Analysis Report by Treatment, Technology, Application, Target Customer, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Radiation Oncology - Global Strategic Business Report - Product Image

Radiation Oncology - Global Strategic Business Report

  • Report
  • 488 Pages
  • Global
From
Radiation Oncology Market Report 2026 - Product Image

Radiation Oncology Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Radiation Oncology Treatment Planning Software Market Report 2026 - Product Image

Radiation Oncology Treatment Planning Software Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Radiation Oncology Market

Radiation Oncology is a branch of Oncology Drugs that uses radiation to treat cancer. It is a form of cancer treatment that uses high-energy radiation to kill cancer cells and shrink tumors. Radiation therapy is used to treat a variety of cancers, including breast, prostate, lung, and brain cancer. It is often used in combination with other treatments, such as chemotherapy and surgery. Radiation therapy works by damaging the DNA of cancer cells, which prevents them from growing and dividing. Radiation Oncology is a rapidly growing field, with new technologies and treatments being developed to improve outcomes for patients. It is an important part of the overall cancer treatment landscape, and is often used in combination with other treatments to maximize the effectiveness of cancer treatment. Some companies in the Radiation Oncology market include Varian Medical Systems, Elekta, Accuray, and IBA. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.